Latest Insider Transactions at Vicarious Surgical Inc. (RBOT)
This section provides a real-time view of insider transactions for Vicarious Surgical Inc. (RBOT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Vicarious Surgical Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Vicarious Surgical Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 23
2021
|
Sammy Khalifa Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
155,900
+50.0%
|
-
|
|
Nov 23
2021
|
David Michael Styka Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,624
+50.0%
|
-
|
|
Nov 23
2021
|
Donald F Tang Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,709
+50.0%
|
-
|
|
Nov 23
2021
|
William John Kelly CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
52,062
+50.0%
|
-
|
|
Sep 17
2021
|
Chelvey International LTD |
BUY
Grant, award, or other acquisition
|
Direct |
10,036,850
+50.0%
|
-
|
|
Sep 17
2021
|
Adam David Sachs CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,329,695
+50.0%
|
-
|
|
Sep 17
2021
|
Barry Stuart Greene > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
17,207
+50.0%
|
-
|
|
Sep 17
2021
|
Barry Stuart Greene > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
3,908,497
+50.0%
|
-
|
|
Sep 17
2021
|
Innovation Endeavors Iii LP > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
13,436,810
+50.0%
|
-
|
|
Sep 17
2021
|
Sammy Khalifa Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,551,668
+50.0%
|
-
|
|
Sep 17
2021
|
D8 Sponsor LLC Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,535,000
+50.0%
|
-
|
|
Sep 17
2021
|
Khosla Ventures V, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
333,334
+2.49%
|
$3,333,340
$10.0 P/Share
|